MedShadow

CDK inhibitors appear to be less toxic than previous breast cancer treatments and autism risk slightly higher in children born to moms that took antidepressants.

Surgery for early-stage prostate cancer hardly improves a man’s lifespan compared to just monitoring the cancer, though the procedure can lead to long-term side effects.

Seniors taking 5 or more medications are more prone to experience falls and walk more slowly.

A new “action plan” proposed by an independent panel calls on the FDA to review the safety and effectiveness of current opioids and re-examine new opioids every few years after approval.

A leukemia drug pulled from the market over questions about efficacy and toxicity may be returning to market and legislation would allow device makers to delay reporting malfunctions.

A dramatic rise in prescribing of cardiovascular drugs, painkillers and insulin may be a key reason why unintentional medication errors are growing.

FDA Commissioner Scott Gottlieb has proposed opioid drugmakers provide educational materials to doctors to more responsibly prescribe immediate-release opioids.